BioPharma Dive July 3, 2023
Sponsored content By iliomad Health Data

U.S. life sciences companies that conduct trials in Europe must deal with more than language nuances and time-zone differences. They must also comply with the General Data Protection Regulation (GDPR). This bedrock privacy regulation controls the use of all personal data, not just health data, of persons residing in the EU and the UK. And thanks to its extraterritorial scope, it applies to U.S. trial sponsors, even if they don’t have offices in the EU and the UK.

In this article, we’ll discuss what the GDPR is and why it matters to your life sciences company. We’ll also show you how iliomad Health Data can help you maintain GDPR compliance.

A Brief Overview of the GDPR

The EU adopted the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Privacy / Security, Regulations, Trends
Where do Psychedelics Fit in the Future of Psychiatry?
2024: record year for AI trials
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape

Share This Article